HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyotaka Yokogami Selected Research

Therapeutics

7/2020[A Case of Transorbital Penetrating Cavernous Sinus Injury by a Bamboo Stick Treated by Craniotomy in the Hybrid Operating Room].
1/2016Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
10/2011Oligodendroglial ganglioglioma.
4/2004Appearance of early venous filling during intra-arterial reperfusion therapy for acute middle cerebral artery occlusion: a predictive sign for hemorrhagic complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyotaka Yokogami Research Topics

Disease

11Neoplasms (Cancer)
01/2021 - 06/2003
6Glioma (Gliomas)
04/2022 - 06/2003
3Germinoma
01/2022 - 08/2015
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2022 - 08/2015
3Glioblastoma (Glioblastoma Multiforme)
11/2019 - 06/2017
2Hemorrhage
07/2020 - 04/2004
1Testicular Neoplasms (Testicular Cancer)
01/2022
1Hemangioblastoma
12/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2020
1Seizures (Absence Seizure)
06/2020
1Epilepsy (Aura)
06/2020
1Leukemia
11/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2018
1Meningitis
06/2017
1Hypersensitivity (Allergy)
06/2017
1Choriocarcinoma
08/2015
1Hypoxia (Hypoxemia)
07/2013
1Neoplasm Metastasis (Metastasis)
01/2013
1Neuroblastoma
01/2013
1Cysts
10/2011
1Hematoma
04/2004
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2004
1Carcinoma (Carcinomatosis)
06/2003
1Brain Neoplasms (Brain Tumor)
06/2003

Drug/Important Bio-Agent (IBA)

3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2022 - 02/2015
2MethyltransferasesIBA
01/2018 - 01/2013
2AcidsIBA
06/2017 - 06/2003
2Gadolinium DTPA (Magnevist)FDA Link
10/2011 - 06/2003
2Indicators and Reagents (Reagents)IBA
04/2004 - 06/2003
1AntigensIBA
01/2022
1Hemostatics (Antihemorrhagics)IBA
07/2020
1Anticonvulsants (Antiepileptic Drugs)IBA
06/2020
1SteroidsIBA
06/2020
1Biological ProductsIBA
11/2019
1Transcription Factors (Transcription Factor)IBA
11/2019
1squamous cell carcinoma-related antigenIBA
06/2018
1hydrogen sulfite (bisulfite)IBA
01/2018
1Carmustine (FIVB)FDA Link
06/2017
1poliferprosan 20 drug combination carmustine (Gliadel)FDA Link
06/2017
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
08/2015
1Messenger RNA (mRNA)IBA
08/2015
1Keratins (Keratin)IBA
02/2015
1Biomarkers (Surrogate Marker)IBA
02/2015
1Glial Fibrillary Acidic ProteinIBA
02/2015
1ErbB Receptors (EGF Receptor)IBA
02/2015
1DNA (Deoxyribonucleic Acid)IBA
02/2015
1ElementsIBA
07/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2013
1CytokinesIBA
07/2013
1Temozolomide (Temodar)FDA LinkGeneric
01/2013
1Irinotecan (Camptosar)FDA LinkGeneric
01/2013
1Contrast MediaIBA
10/2011
1GadoliniumIBA
06/2003
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
06/2003

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2022 - 01/2013
4Therapeutics
07/2020 - 04/2004
3Craniotomy
12/2021 - 06/2018
2Lasers (Laser)
01/2019 - 02/2015
1Catheters
07/2020
1Operative Surgical Procedures
06/2020
1Stem Cell Transplantation
01/2013